Enzyme mutations may protect against vascular thrombosis and stroke

January 7, 2014 by Helen Dodson
Enzyme mutations may protect against vascular thrombosis and stroke
Credit: Shutterstock

(Medical Xpress)—Yale researchers have identified the mechanism behind a molecular variation that reduces risk of stroke in children with sickle cell anemia. The molecular variation was recently identified but not understood due to a limited grasp of the gene's role in hemostasis—the stopping of bleeding. These new findings open a path for the development of novel drugs that may prevent stroke, particularly in children with sickle cell anemia who are at risk of this devastating complication. The study appears online in the Journal of Biological Chemistry.

The researchers demonstrate that an enzyme known as NPP1, encoded by the gene associated with protection, is part of a family of enzymes that encourages the coagulation of blood on vascular surfaces. Too much clotting on the vascular lining can lead to thrombosis and stroke. By demonstrating that NPP1 can induce platelet aggregation at low concentrations (on the vascular lining, for example), the team established a direct role for the enzyme in thrombotic stroke.

"Our findings strongly suggest that NPP1 inhibitors would confer some level of stroke protection to patients at risk for thrombotic stroke, especially to children with in whom the NPP1 variation was identified," said senior author Demetrios Braddock, M.D., associate professor of pathology at Yale School of Medicine.

The team also determined the molecular structure of a close relative of NPP1 called NPP4, which revealed the molecular details of the target site for new inhibitors directed against the gene—further enabling the possible design of novel anti-stroke drugs.

Explore further: Sickle cell anemia stroke prevention efforts may have decreased racial disparities

More information: Ronald A. Albright, Deborah L. Ornstein, Wenxiang Cao, William C. Chang, Donna Robert, Martin Tehan, Denton Hoyer, Lynn Liu, Paul Stabach, Guangxiao Yang, Enrique M. De La Cruz, and Demetrios T. Braddock. "The Molecular Basis of Purinergic Signal Metabolism by Ecto-Nucleotide Pyrophosphatase/Phosphodiesterases 4 and 1 and Implications in Stroke." J. Biol. Chem. jbc.M113.505867. First Published on December 12, 2013, DOI: 10.1074/jbc.M113.505867

Related Stories

Sickle cell anemia stroke prevention efforts may have decreased racial disparities

February 2, 2012
The disparity in stroke-related deaths among black and white children dramatically narrowed after prevention strategies changed to include ultrasound screening and chronic blood transfusions for children with sickle cell ...

Risk of death from ischemic stroke appears to have decreased in US black children

June 24, 2013
The excess risk of death from ischemic (due to reduced blood flow), but not hemorrhagic (due to bleeding), stroke in US black children has decreased over the past decade, according to a study by Laura L. Lehman, M.D., of ...

Stroke-causing mutant gene identified by scientists—along with a potential treatment

September 4, 2013
(Medical Xpress)—A genetic mutation that can lead to haemorrhagic stroke has been identified by scientists – along with a drug to potentially treat it.

Shingles linked to increased risk of stroke in young adults

January 2, 2014
Having shingles may increase the risk of having a stroke years later, according to research published in the January 2, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

High blood pressure, anemia put children with sickle cell disease at risk for silent strokes

November 29, 2011
A team of researchers from the Johns Hopkins Children's Center, Vanderbilt University and elsewhere have demonstrated that high blood pressure and anemia together put children with sickle cell disease (SCD) at serious danger ...

Recommended for you

Five vascular diseases linked to one common genetic variant

July 27, 2017
Genome-wide association studies have implicated a common genetic variant in chromosome 6p24 in coronary artery disease, as well as four other vascular diseases: migraine headache, cervical artery dissection, fibromuscular ...

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.